|
View the Kos Pharmaceuticals company profile on LinkedIn. See recent hires and promotions, competitors and how you’re connected to Kos Pharmaceuticals. ... KOS Pharmaceuticals, Inc. engages in the development and commercialization of prescription products for the treatment of chronic cardiovascular, metabolic,
|
www.linkedin.com/companies/kos-pharmaceuticals
www.linkedin.com/companies/kos-pharmaceuticals
|
|
|
|
ABBOTT PARK, Illinois (AFX) - Abbott said it has agreed to buy Kos Pharmaceuticals Inc, a New Jersey-based specialist in treating chronic cardiovascular, metabolic and respiratory disease, for 78 usd per share in cash, or a total 3.7 bln usd. ... The deal is expected to result in unspecified one-time charges, ... AFX News Limited...
|
www.forbes.com/markets/feeds/afx/2006/11/06/afx3147653....
www.forbes.com/markets/feeds/afx/2006/11/06/afx3147653.html
|
|
|
CT ORDER KOS PHARMACEUTICALS INC 08/08/08 ... SC 13G/A KOS PHARMACEUTICALS INC (GOLDMAN SACHS ASSET MANAGEMENT LP) 02/09/07 ... SC 13D/A KOS PHARMACEUTICALS INC (JAHARIS MARY) 12/18/06...
|
www.edgar-online.com/brand/yahoo/search/?cik=1018952
|
|
Kos Pharmaceuticals (KOSP) Reports A 17% Increase In Revenue, Earnings Per Share Of $0.71, And Solid Cash Flow From Operations 11/9/2006 11:46:11 AM More... ... Kos Pharmaceuticals (KOSP) Announces Overall Results For Two Phase III Trials Of Icatibant For The Treatment Of Hereditary Angioedema; Primary Endpoint Met...
|
www.biospace.com/company_profile.aspx?CompanyId=2297
|
|
News on Kos Pharmaceuticals continually updated from thousands of sources around the net. ... Kos Pharmaceuticals News Editors ... People just like you make Kos Pharmaceuticals News on Topix better every day. If you're interested in becoming an editor, apply today!
|
www.topix.net/com/kosp
www.topix.net/com/kosp
|
|
After Hours: 0.00 N/A (N/A) 7:00pm ET ... KOS Pharmaceuticals, Inc. engages in the development and commercialization of prescription products for the treatment of chronic cardiovascular, metabolic, and respiratory diseases. View More ... KOS Pharmaceuticals Inc. (KOSP)
|
finance.yahoo.com/q?s=kosp
finance.yahoo.com/q?s=kosp
|
|
Making believers of Dr. Chavez and other physicians is a critical hurdle for Abbott Laboratories Inc., which has placed a big bet on HDL-boosting drugs with its proposed $3.7-billion acquisition of Kos Pharmaceuticals Inc.
|
findarticles.com/p/articles/mi_hb5253/is_200612/ai_n202...
findarticles.com/p/articles/mi_hb5253/is_200612/ai_n20200052
|
|
Free Online Library: Kos Pharmaceuticals Broadens Leadership Team. by "Business Wire"; Business, international Pharmaceutical industry ... Kos Pharmaceuticals, Inc. (Nasdaq:KOSP) announced today that it has appointed new senior executives to its leadership team. In two newly created positions, Andrew Koven joins Kos as...
|
www.thefreelibrary.com/Kos+Pharmaceuticals+Broadens+Lea...
www.thefreelibrary.com/Kos+Pharmaceuticals+Broadens+Leadership+Team-a0108605390
|
|
Department of Health and Human Services ... Public Health Service ; Food and Drug Administration ... Mr. Adrian Adams; President and CEO; Kos Pharmaceuticals Inc. 1001 Brickell Bay Drive 25” Floor; Miami, Florida 33131;
|
www.fda.gov/ICECI/EnforcementActions/WarningLetters/200...
www.fda.gov/ICECI/EnforcementActions/WarningLetters/2003/ucm147897.htm
|
|
